Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$6.86 - $8.79 $92,610 - $118,664
-13,500 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$6.31 - $8.4 $3,155 - $4,200
-500 Reduced 3.57%
13,500 $113,000
Q2 2021

Aug 12, 2021

SELL
$6.25 - $8.25 $9,375 - $12,375
-1,500 Reduced 9.68%
14,000 $97,000
Q1 2021

May 13, 2021

SELL
$4.95 - $7.7 $44,550 - $69,300
-9,000 Reduced 36.73%
15,500 $96,000
Q4 2020

Feb 09, 2021

SELL
$3.67 - $5.1 $13,395 - $18,615
-3,650 Reduced 12.97%
24,500 $125,000
Q3 2020

Nov 06, 2020

SELL
$4.33 - $6.05 $58,455 - $81,675
-13,500 Reduced 32.41%
28,150 $124,000
Q2 2020

Aug 12, 2020

SELL
$4.9 - $6.14 $90,650 - $113,590
-18,500 Reduced 30.76%
41,650 $231,000
Q1 2020

May 11, 2020

SELL
$4.63 - $10.62 $51,161 - $117,350
-11,050 Reduced 15.52%
60,150 $364,000
Q4 2019

Feb 13, 2020

SELL
$8.7 - $9.79 $13,049 - $14,684
-1,500 Reduced 2.06%
71,200 $651,000
Q3 2019

Nov 12, 2019

SELL
$7.2 - $10.2 $67,910 - $96,206
-9,432 Reduced 11.48%
72,700 $662,000
Q2 2019

Aug 13, 2019

SELL
$9.5 - $14.5 $109,259 - $166,764
-11,501 Reduced 12.28%
82,132 $1.17 Million
Q1 2019

May 14, 2019

SELL
$13.83 - $19.63 $174,258 - $247,338
-12,600 Reduced 11.86%
93,633 $1.33 Million
Q4 2018

Feb 14, 2019

SELL
$14.15 - $18.99 $7,075 - $9,495
-500 Reduced 0.47%
106,233 $1.69 Million
Q3 2018

Nov 13, 2018

SELL
$18.7 - $21.72 $58,905 - $68,418
-3,150 Reduced 2.87%
106,733 $2.01 Million
Q2 2018

Aug 13, 2018

SELL
$18.55 - $21.37 $111,300 - $128,220
-6,000 Reduced 5.18%
109,883 $2.11 Million
Q1 2018

May 15, 2018

SELL
$19.52 - $22.64 $9,896 - $11,478
-507 Reduced 0.44%
115,883 $2.48 Million
Q4 2017

Feb 14, 2018

SELL
$16.63 - $21.24 $184,127 - $235,169
-11,072 Reduced 8.69%
116,390 $2.39 Million
Q3 2017

Nov 13, 2017

BUY
$17.43 - $21.51 $2.22 Million - $2.74 Million
127,462
127,462 $2.35 Million

Others Institutions Holding PMD

About PSYCHEMEDICS CORP


  • Ticker PMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 5,626,200
  • Market Cap $13.2M
  • Description
  • Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, ...
More about PMD
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.